OXIS DEFINITIVE PROXY 2006

Company

GT Biopharma, Inc.

Filed

June 15, 2006

Period of Report

August 1, 2006

Accession Number

0000109657-06-000034

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →